FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

429825009: Fosaprepitant (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2008. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2708791018 Fosaprepitant (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2764623019 Fosaprepitant en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
373821000195118 fosaprepitant it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
813341000172118 fosaprépitant fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
904971000195110 Fosaprepitant de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Fosaprepitant (substance) Is a Neurokinin 1 receptor antagonist true Inferred relationship Some
Fosaprepitant (substance) Is a Triazole derivative false Inferred relationship Some
Fosaprepitant (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Neurokinin 1 receptor antagonist (disposition) true Inferred relationship Some
Fosaprepitant (substance) Is a Substance with triazole structure (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Fosaprepitant dimeglumine (substance) Is a False Fosaprepitant (substance) Inferred relationship Some
Product containing fosaprepitant (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fosaprepitant (substance) Inferred relationship Some 1
Fosaprepitant 115mg powder for injection solution 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Fosaprepitant (substance) Inferred relationship Some
Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Fosaprepitant (substance) Inferred relationship Some 1
Fosaprepitant dimeglumine (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Fosaprepitant (substance) Inferred relationship Some
Product containing fosaprepitant in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fosaprepitant (substance) Inferred relationship Some 1
Fosaprepitant only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fosaprepitant (substance) Inferred relationship Some 1
Fosaprepitant only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Fosaprepitant (substance) Inferred relationship Some 1
Fosaprepitant (as fosaprepitant dimeglumine) 150 mg powder for solution for infusion vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Fosaprepitant (substance) Inferred relationship Some 1
Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for infusion vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Fosaprepitant (substance) Inferred relationship Some 1
Product containing precisely fosaprepitant (as fosaprepitant dimeglumine) 115 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Fosaprepitant (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start